MAPbI3 / FAPbI3 hybrid organic-inorganic; PCE 3.8 percent (2009 Miyasaka) to 26.1 percent (2024 NREL); cheap solution-process; stability + lead-toxicity major challenges.
MAPbI3 / FAPbI3 hybrid organic-inorganic; PCE 3.8 percent (2009 Miyasaka) to 26.1 percent (2024 NREL); cheap solution-process; stability + lead-toxicity major challenges.